AIM Vaccine Co., Ltd.

HK$1.56As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6660Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (52.03%)
Div yield —
ROE (23.23%)
Biotechnology
Beta (5Y) 0.10
PE TTM —
TSR TTM (60.10%)
Mkt cap HK$1.913B
ROIC (4.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.87
19.96%
(59.59%)
Hold 7|11|8|10|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.03
15.92%
12.24%
4.46%
(4.13%)
Revenue¥M
94.16
99.14
100.6
102.9
16.68%
22.77%
17.63%
14.12%
Peers (US$244.1M)
Cap (US$)
PE
269.1M
179.9x
244.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.118
(1.349)
(1.027)
EBIT/Intx
0.871
0.090
0.090
Own earn%
194.82
(50.13)
(37.37)
Sh yield%
14.28
53.32
48.06
Owners
Insiders/Inst%
0.57
30.71
Short interest%
0.55
SBC / revenue%
5.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–19
$1 testx
0.0
Incr. ROIC%
6